辛伐他汀治疗冠心病心绞痛急性发作的临床效果

杨万根

（陕西省商洛疗养院，陕西 商洛，726000）

浏览次数：88次 下载次数：378次

摘要：

目的 探讨辛伐他汀治疗冠心病心绞痛急性发作的临床效果。方法 选取2015 年5 月至2016 年5 月我院收治的72 例冠心 病心绞痛急性发作患者为研究对象，随机分为试验组与对照组，各36 例。对照组患者实施常规治疗，试验组在对照组基础上加用 辛伐他汀。比较两组患者的临床疗效。结果 试验组的治疗总有效率为97.22%，显著高于对照组的72.22%（P<0.05）；治疗后，两组患者 的心绞痛发作持续时间、发作次数、TG 及TC 水平均明显优于治疗前，且试验组明显优于对照组（P<0.05）。结论 对冠心病急性 心绞痛发作患者实施辛伐他汀治疗，能够明显缓解患者的心绞痛发作症状，改善患者的TG、TC 水平，值得在临床上推广应用。

关键词：辛伐他汀；冠心病；心绞痛

中图分类号：R541.4文献标志码：A文章编号：2096-1413(2018)04-0023-02

Clinical effect of simvastatin in the treatment of acute attack of angina pectoris and coronary heart disease
YANG Wan-gen
(Shangluo Sanatorium, Shangluo 726000, China)

ABSTRACT: Objective To investigate the clinical effect of simvastatin in the treatment of acute attack of angina pectoris and coronary heart disease. Methods Seventy-two cases of patients with acute attack of angina pectoris and coronary heart disease admitted in our hospital were selected and randomly divided into experimental group and control group, with 36 cases in each group. The control group was treated with routine treatment, and the experimental group was given simvastatin on the basis of the control group. The clinical effects of the two groups were compared. Results The total effective rate of the experimental group was 97.22%, which was higher than 72.22% of the control group (P<0.05). After treatment, the duration and attack times of angina pectoris, levels of glycerin triacylglycerol (TG) and total cholesterol (TC) in the two groups were better than those before treatment, and those in the experimental group were better than the control group (P<0.05). Conclusion Using simvastatin in the treatment of acute attack of angina pectoris and coronary heart disease can obviously relieve the symptoms of angina pectoris, and improve the TG and TC levels, which is worth popularizing in clinic.

KEYWORDS: simvastatin; coronary heart disease; angina pectoris

参考文献：
[1] 周云.麝香保心丸在冠心病心绞痛急性发作中的应用分析[J].亚太传统医药,2014,10(11):117-118.
[2] 戴榕,周军,冷沁.老年冠心病心绞痛患者急性发作期前列地尔临床用药研究[J].安徽医药,2016,20(2):378-379.
[3] 贾振华,吴以岭,高怀林,等.基于熵的复杂系统分划方法与冠心病心绞痛证候量化诊断标准研究[J].中医杂志,2008,49(5):459-461.
[4] 黄勤,李彬.辛伐他汀联合氯吡格雷和低分子肝素治疗冠心病心绞痛的临床疗效评价[J].现代诊断与治疗,2014,26(16):3710-3712.
[5] 武雅琴.辛伐他汀缓解缺血再灌注肺损伤的机制研究[D].南京:南京医科大学,2012.
[6] 仲英玉.他汀类药物治疗冠心病心绞痛的临床疗效观察[J].中国医药指南,2016,14(31):166-167.
[7] 郭雨青,甄毅锋,石雁.通心络胶囊联合他汀类药物治疗冠心病心绞痛疗效观察[J].现代中西医结合杂志,2016,25(10):1115-1117.
[8] 李军朋,高爱红,刘积伦,等.美托洛尔联合辛伐他汀治疗老年不稳定型心绞痛患者的效果及对CRP、BNP 水平的影响[J].疑难病杂 志,2016,15(2):139-142.